Opinion: The Public Is Unified On Lowering Drug Prices. Why Are Leaders Settling For Less?
PhRMA regards drug price negotiation for Medicare as an existential threat to its business — potentially costing billions.
pharma
As Big Pharma And Hospitals Battle Over Drug Discounts, Patients Miss Out On Millions In Benefits
Congress created the 340B program to provide extra funding for hospitals and clinics, but some pharmaceutical manufacturers are refusing to honor the federal drug discount program.
Making Sense of Congressional Prescription Drug Pricing Proposals
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
A look at the policies on the table and what they will and won’t do to rein-in the cost of pharmaceuticals.
Protesters Decry Schrader's Vote Against Drug Pricing Plan
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Activists demonstrated outside the U.S. Congressman's Oregon City district office in protest of his vote opposing a proposal to lower prescription drug prices.
Loopholes, Lack Of Staffing Stymie Transparency Of Oregon’s Drug Pricing Program
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The state’s Prescription Drug Price Transparency Program was created to illuminate pharmaceutical pricing practices, but pharmaceutical companies have shielded information they say infringes on trade secrets.
National Academies’ Report Took Pharma-Friendly Stance After Millions in Gifts From Drugmakers
The report, which failed to disclose conflicts of interest, advised against an effort by Medicare to recoup millions for discarded drugs.
Pharmacies Face Extra Audit Burdens That Threaten Their Existence
Pharmacy benefit managers switched to virtual audits during the pandemic, which increased reviews, payment denials and their profits.
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Ozempic’s peppy ads suggest that people who use it might lose weight, but also include a disclaimer: that it “is not a weight loss drug.” Now — as Wegovy — it is.
Pfizer Court Fight Could Legalize Medicare Copays And Unleash ‘Gold Rush’ in Sales
A Pfizer win in a lawsuit against the federal government could cost taxpayers billions of dollars and erase an important control on pharma marketing after decades of regulatory erosion and soaring drug prices, say health policy analysts.
New Alzheimer’s Drug Manufacturer Launches Controversial Campaign
Facing a host of challenges, Aduhelm’s makers are running an educational campaign directed at consumers who are worried about whether their forgetfulness is a sign of disease.
Pages
